Duodenal Microbiome and Serum Metabolites Predict Hepatocellular Carcinoma in a Multicenter Cohort of Patients with Cirrhosis

BACKGROUND: Hepatocellular carcinoma (HCC) is rapidly increasing in the U.S. and is a leading cause of mortality for patients with cirrhosis. Discovering novel biomarkers for risk stratification of HCC is paramount. We examined biomarkers of the gut-liver axis in a prospective multicenter cohort. ME...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Tien S., Jacobs, Jonathan P., Agopian, Vatche, Pisegna, Joseph R., Ayoub, Walid, Durazo, Francisco, Enayati, Pedram, Sundaram, Vinay, Benhammou, Jihane N., Noureddin, Mazen, Choi, Gina, Lagishetty, Venu, Fiehn, Oliver, Goodman, Marc T., Elashoff, David, Hussain, Shehnaz K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9287237/
https://www.ncbi.nlm.nih.gov/pubmed/34799768
http://dx.doi.org/10.1007/s10620-021-07299-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9287237/
https://www.ncbi.nlm.nih.gov/pubmed/34799768
http://dx.doi.org/10.1007/s10620-021-07299-2

Ejemplares similares